Design Therapeutics (DSGN) Total Liabilities (2020 - 2026)

Design Therapeutics' Total Liabilities history runs 7 years deep, the most recent figure standing at $12.4 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 29.64% year-over-year to $12.4 million; the TTM figure through Mar 2026 stood at $12.4 million (up 29.64% YoY), while the FY2025 annual figure was $13.7 million, up 37.05% from the prior year.
• Total Liabilities came in at $12.4 million for Q1 2026 at Design Therapeutics, down from $13.7 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $14.9 million in Q3 2023 to a low of $8.3 million in Q2 2024.
• A 5-year average of $11.4 million and a median of $11.9 million in 2023 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities jumped 203.78% in 2022 and plunged 43.78% in 2024, its largest moves.
• Design Therapeutics' Total Liabilities stood at $13.8 million in 2022, then fell by 13.53% to $12.0 million in 2023, then dropped by 16.39% to $10.0 million in 2024, then jumped by 37.05% to $13.7 million in 2025, then decreased by 9.58% to $12.4 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $12.4 million, $13.7 million, and $12.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison